affluent 发表于 2025-3-25 04:33:59

Submitted on: 13 June 2022.
Revised on: 13 August 2022.
Accepted on: 27 September 2022.

___________________Current Cancer Therapy Reviews

收藏品 发表于 2025-3-25 10:49:06

http://reply.papertrans.cn/1/69/6860/6860-22.png

标准 发表于 2025-3-25 12:42:19

http://reply.papertrans.cn/1/69/6860/6860-23.png

patriot 发表于 2025-3-25 16:26:03

Submitted on: 26 May 2023.
Revised on: 20 September 2023.
Accepted on: 10 November 2023.

___________________Current Cancer Therapy Reviews

Antioxidant 发表于 2025-3-25 22:19:26

http://reply.papertrans.cn/1/69/6860/6860-25.png

矛盾心理 发表于 2025-3-26 03:24:03

Submitted on: 07 August 2006.
Revised on: 29 November 2006.
Accepted on: 24 December 2006.

___________________Current Cancer Therapy Reviews

patella 发表于 2025-3-26 06:31:55

http://reply.papertrans.cn/1/69/6860/6860-27.png

Silent-Ischemia 发表于 2025-3-26 09:37:04

http://reply.papertrans.cn/1/69/6860/6860-28.png

AWRY 发表于 2025-3-26 13:04:20

Submitted on: 09 July 2024.
Revised on: 01 October 2024.
Accepted on: 21 November 2024.

___________________Current Cancer Therapy Reviews

ADJ 发表于 2025-3-26 17:25:31

http://reply.papertrans.cn/1/69/6860/6860-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Current Cancer Therapy Reviews 2024/2025影响因子:0.483 (CURR CANCER THER REV) (1573-3947). (ONCOLOGY)(肿瘤学)Emerging So